Effects of metyrapone in patients with mild hypercortisolism
Low-dose evening metyrapone appears to be a safe and potentially effective option for improving BP control in patients with mH, especially those with higher baseline systolic pressure.
Authors
- Valentina Morelli (ORCID: https://orcid.org/0000-0002-6716-3045)
- Vittoria Favero (ORCID: https://orcid.org/0000-0001-6109-423X)
- Sabrina Corbetta (ORCID: https://orcid.org/0000-0001-8140-3175)
- Luca Persani (ORCID: https://orcid.org/0000-0003-2068-9581)
- Carmen Aresta (ORCID: https://orcid.org/0000-0002-5390-2134)
- Iacopo Chiodini (ORCID: https://orcid.org/0000-0001-7594-3300)
- Chiara Parazzoli (ORCID: https://orcid.org/0000-0002-6789-3961)
- Stefano Testa
- Antonio Musolino (ORCID: https://orcid.org/0000-0002-3316-957X)
Institutions
- University of Milan (IT)
- Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (IT)
- IRCCS Istituto Auxologico Italiano (IT)
Publication Details
- Journal
- European Journal of Endocrinology
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1093/ejendo/lvaf216
- Citations
- 2
- Primary Topic
- Pituitary Gland Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.59